India: Court Refuses Injunction Holding Concurrent Use Must be Honest

Last Updated: 22 August 2007
Article by Manisha Singh

In yet another case the question as to the superiority of use over registration of a trademark came up for decision before the Delhi High Court. In Sun Pharmaceutical Industries Limited v. Cipla Limited 2007 (34) PTC 481 (Bom.) Cipla /Defendant had adopted the trademark "Graniset" in February, 1998 for a drug used for treating Chemotherapy and other similar therapies related nausea and vomiting. At that time no one was either using the said trademark or had applied for its registration. Accordingly, Cipla applied for registration in Class 5 in 1998. After advertisement of the application, the registration was granted in 2005 as no one opposed the application. After grnat of registration, Cipla started using the said trademark for its drug from July 2005. In 1999 Sun Pharmaceutical/Plaintiff also applied for an identical trademark "Graniset" in Class 5 for a drug used for identical treatment as that of Cipla. However, the compositions of both the drugs were different. The Active Pharmaceutical Ingredient (API) in Sun’s drug was "Granisetron" whereas the API in Cipla’s drug was "Ondansetron". Sun claimed to be have commenced the use of the said mark in respect of the drug on 1.12.2000. In consequence of Sun’s claimed use of an identical mark, Cipla filed a suit in the District Court of Delhi against Sun for infringement and passing off for their trademark ‘Grainset’. In that suit, Sun filed made a counter claim seeking an injunction against Cipla restraining it from using the trademark "Grainset" and/or any other identical or deceptively similar mark in respect of drugs.

Pending the disposal of its counterclaim in the above suit before the District Court in Delhi, Sun filed a fresh suit for identical relief before the Bombay High Court.


Sun submitted that mere registration of the trademark in the name of "Cipla" did not create any association with the product and hence of no consequence. The right to prevent passing off comes only with the usage of the mark and registration of the mark does not confer that right. Since Sun was prior user of the impugned mark, Sun was entitled to restrain Cipla from using the identical and/or deceptively similar trademark in respect of drugs and medicines. Sun contented even though the adoption of the trademark "Grainset" by it was later to Cipla but it was honest adoption being derived from API of its drug "Grainsetron".

Cipla on the other hand contented that since the registration of the trademark "Grainset" in Class 5 already existed in its name, Sun was duty bound to search the Trademark Register before adopting and using an identical mark in respect of the identical goods. Cipla further contented that relief of passing off cannot be granted to Sun merely because Sun’s prior use of Cipla’s registered trademark. It pointed out that adoption and use by Sun of an identical mark in respect of an identical drug was in bad faith. Cipla also pointed out that Sun had already sought an identical relief by way of a pending interlocutory application in the suit filed in Delhi and in order to falsely invoke the jurisdiction of the Bombay High Court, Sun had concealed this fact in the pleadings in bad faith.


The Bombay High Court considered the question of aforesaid concealment of facts by Sun and held such concealment amounted to material suppression therefore; Sun was not entitled to interim relief on that count. On the question of the claim of injunction on prior use, Sun placed on record a plethora of cases that upheld the superiority of prior use over registration. The Court was of the view that it was possible to conceive that Sun was entitled to injunction on the basis of prior use, but it was necessary to establish beyond doubt that such adoption was completely innocent and honest. On analyzing the reasons for adoption of an identical mark by Sun, the Court overruled its explanation that it relied on market search and did not find any drug with similar or identical mark in the market. The Court held that from record it appears that Sun had prima facie knowledge of Cipla’s trademark when Sun applied for the registration of the identical mark for an identical drug. In the absence of a Trademark Search Report on record, the Court rejected the pleadings of Sun that it had conducted a prior search in the Trademark Register before adopting and applying for the trademark "Grainset".

After a week of closing the matter for Orders, Sun sought leave of the Court to adduce additional evidences in respect of the Trademark search conducted by it, but the Court denied Sun’s request for being belated and refused injunction against Cipla.

The case affirms the principle that use of a trademark plays all-important role provided that such adoption and use of the said trademark was innocent and honest.

© Lex Orbis 2007

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions